Search clinical trials for: Lorlatinib
Total 53 results
-
Centro di Riferimento Oncologico - AvianoRecruitingNon Small Cell Lung Cancer Metastatic | ALK Gene MutationItaly
-
Sichuan Cancer Hospital and Research InstituteRecruitingALK-positive Non-small Cell Lung Cancer | Real World StudyChina
-
Nationwide Children's HospitalPfizerNot yet recruitingGlioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | WHO Grade III Glioma | WHO Grade IV Glioma | Infant Type Hemispheric Glioma | Diffuse Midline Glioma, H3K27-alteredUnited States, Australia, Canada, Germany, Netherlands
-
Guangdong Association of Clinical TrialsNot yet recruitingCarcinoma, Non-Small-Cell Lung | Brain Metastases | Leptomeningeal MetastasisChina
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingNSCLC Stage IV | ALK Gene Mutation | ALK Sensitizing MutationItaly
-
Guangdong Association of Clinical TrialsRecruitingALK Positive Non-small Cell Lung CancerChina
-
Memorial Sloan Kettering Cancer CenterEli Lilly and CompanyRecruitingNon Small Cell Lung Cancer | Metastatic | RecurrentUnited States
-
PfizerRecruitingNon-Small Cell Lung CancerNorway
-
Guangdong Provincial People's HospitalRecruiting
-
PfizerRecruitingHealthy Volunteers | Moderate Hepatic Impairment | Severe Hepatic ImpairmentUnited States
-
PfizerRecruitingNSCLC | Non-Small-Cell Lung CancerSpain, China, Taiwan, France, Singapore, Japan, United States
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruitingNon Small Cell Lung Cancer MetastaticFrance
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung Cancer | ALK Gene Mutation | MET Gene Mutation | EGFR Gene Mutation | ROS1 Gene MutationChina
-
Massachusetts General HospitalPfizer; Array BioPharmaRecruitingNSCLC | Lung Cancer | Relapsed Cancer | Resistant Cancer | MET Amplification | Anaplastic Lymphoma Kinase Gene Translocation | ROS1 RearrangementUnited States
-
National Cancer Center, KoreaRecruiting
-
University of Milano BicoccaPfizerRecruitingAnaplastic Large Cell Lymphoma, ALK-PositiveItaly
-
Massachusetts General HospitalRecruitingNon-Small Cell Lung Cancer (NSCLC)United States
-
The Netherlands Cancer InstituteBristol-Myers Squibb; Eli Lilly and Company; Bayer; GlaxoSmithKline; Merck Sharp... and other collaboratorsRecruitingCancer | Neoplasm | Tumors | NeoplasiaNetherlands
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
Strata OncologyMerck Sharp & Dohme LLC; Pfizer; Gilead SciencesActive, not recruitingCancer | Advanced Solid TumorUnited States
-
Sichuan Cancer Hospital and Research InstituteActive, not recruitingBrain Metastases | ALK-positive Non-small Cell Lung Cancer | Meningeal MetastasisChina
-
PfizerActive, not recruiting
-
Jonsson Comprehensive Cancer CenterActive, not recruitingGlioma | Glioblastoma | Anaplastic Astrocytoma | Anaplastic Astro-oligodendrogliomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | GanglioneuroblastomaUnited States, Canada, Puerto Rico
-
PfizerCompletedALK-positive Non-small-cell Lung CancerJapan
-
CStone PharmaceuticalsPfizerActive, not recruitingAdvanced or Metastatic ROS1-Positive Non-Small Cell Lung CancerChina
-
PfizerActive, not recruitingCarcinoma | Non-Small-Cell LungSpain, United States, United Kingdom, Italy, India, Poland, Switzerland
-
Intergroupe Francophone de Cancerologie ThoraciqueActive, not recruitingNon Small Cell Lung Cancer MetastaticFrance
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
PfizerCompletedNon-Small Cell Lung CarcinomaTaiwan
-
PfizerActive, not recruitingCarcinoma, Non-Small-Cell LungChina
-
PfizerActive, not recruitingCarcinoma, Non-Small-Cell LungCanada, Spain, United States, China, Korea, Republic of, United Kingdom, France, Czechia, Japan, Singapore, Taiwan, Australia, Netherlands, India, Turkey, Hong Kong, Argentina, Belgium, Germany, Italy, Mexico, Poland, Russian Federation
-
European Organisation for Research and Treatment...Active, not recruitingNon Small Cell Lung CancerNetherlands, Spain, France, United Kingdom, Norway, Jordan, Belgium
-
New Approaches to Neuroblastoma Therapy ConsortiumPfizer; University of Southern California; Cookies for Kids' Cancer; The Evan Foundation and other collaboratorsActive, not recruitingNeuroblastomaCanada, United States, France, United Kingdom
-
SCRI Development Innovations, LLCPfizerWithdrawnLung Cancer | Non-small Cell Lung CancerUnited States
-
TakedaCompletedCarcinoma Non-small-cell Lung | Anaplastic Lymphoma Kinase-positiveUnited States
-
Intergroupe Francophone de Cancerologie ThoraciquePfizerCompletedALK Gene Rearrangement Positive | Non-small Cell Lung Cancer Metastatic | ROS-1 Gene Rearrangement PositiveFrance
-
University of Colorado, DenverCancer League of ColoradoCompletedNon Small Cell Lung Cancer | CNS ProgressionUnited States
-
Beijing Friendship HospitalCompleted
-
Fundación GECPCompletedMetastatic Non Small Cell Lung CancerSpain
-
PfizerTerminatedNeuroblastomaAustralia, Korea, Republic of, United States, Portugal, New Zealand, Sweden
-
PfizerCompletedAdvanced Non-Small Cell Lung CancerIndia
-
PfizerTerminated
-
Fondazione Ricerca TraslazionaleClinical research technology SrlActive, not recruitingCarcinoma, Non-Small-Cell LungItaly
-
HRA PharmaCompletedCushing's SyndromeGermany, Belgium, Italy, Hungary, Poland, Romania, Spain, Turkey
-
PfizerCompletedHealthy Volunteers | Adult | Drug Interactions | HumansBelgium
-
PfizerNo longer availableNon Small Cell Lung Cancer ALK Positive or ROS1 PositiveUnited States